Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by David Corry
Virus reactivation in acute and long COVID-19
Abstract Chronic viral infections are ubiquitous in humans, with individuals carrying multiple viruses that can reactivate during physiological stress, including severe illness1. Notably, SARS-CoV-2 infection has been shown to reactivate chronic viruses such as Epstein–Barr virus and cytomegalovirus, yet the full extent, temporal dynamics and immunological impact of viral reactivation in COVID-19 remain incompletely understood2,3,4,5,6,7.
Author Correction: Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors - Communications Medicine
|
Correction to: Communications Medicine https://doi.org/10.1038/s43856-025-01230-w, published online 03 January 2026 In the version of the article initially published, the surname of Linda N. Geng appeared incorrectly (as Gen) and has now been amended in the HTML and PDF versions of the article.
By Naresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena, Annmarie Hoch, Jeremy P. Gygi, Gisela Gabernet, Al Ozonoff, Shanshan Liu, Carly E. Milliren, Ofer Levy, Lindsey R. Baden, Esther Melamed, Lauren I. R. Ehrlich, Grace A McComsey, Rafick P. Sekaly, Charles B. Cairns, Elias Haddad, Joanna Schaenman, Albert Shaw, David A. Hafler, Ruth R. Montgomery, David Corry, Farrah Kheradmand, Mark Atkinson Verified, Scott C Brakenridge, Nelson I. Agudelo Higuit, Jordan P Metcalf, Catherine L. Hough, William Messer, Kari C. Nadeau, Mark Davis, Linda N Geng, Ana Fernandez Sesma, Viviana Simon, Florian Krammer, Monica Kraft, Chris Bime, Carolyn S Calfee, David J. Erle, Charles Langelier, Holden T Maecker, Bjoern Peters, Steven Kleinstein, Elaine Reed, Alison D. Augustine, Joann Diray-Arce, Patrice Becker, Nadine Rouphael, Matthew Altman
|
Nature
Verified
The future of P&C insurance depends on rethinking talent
The 2026 talent cliff in P&C insurance is approaching quickly. (Image credit: InfiniteFlow/Adobe Stock) The insurance industry is approaching a pivotal moment. A significant number of seasoned professionals will reach retirement eligibility by 2026, according to U.S. Bureau of Labor Statistics projections, accelerating a talent gap that has been widening for years. The question is no longer whether the industry will feel the impact; it's whether we are prepared for it.
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors - Communications Medicine
|
Abstract The post-acute sequelae of SARS-CoV-2 (PASC), also known as long COVID, remain a significant health issue that is incompletely understood. Predicting which acutely infected individuals will develop long COVID is challenging due to the absence of established biomarkers, clear disease mechanisms, or well-defined sub-phenotypes. Machine learning (ML) models may address this gap by leveraging clinical data to enhance diagnostic precision.
By Naresh Doni Jayavelu, Hady Samaha, Annmarie Hoch, Gisela Gabernet, Al Ozonoff, Carly E. Milliren, Ofer Levy, Lindsey R. Baden, Esther Melamed, Grace A McComsey, Rafick P. Sekaly, Charles B. Cairns, Elias Haddad, David A. Hafler, Ruth R. Montgomery, David Corry, Farrah Kheradmand, Mark Atkinson Verified, Scott C Brakenridge, Jordan P Metcalf, William Messer, Kari C. Nadeau, Mark Davis, Ana Fernandez Sesma, Viviana Simon, Florian Krammer, David J. Erle, Charles Langelier, Holden T Maecker, Bjoern Peters, Steven Kleinstein, Joann Diray-Arce, Patrice Becker, Nadine Rouphael
|
Nature
Verified
How to Avoid Skin Rash From Diabetes Medical Devices
Skin rash from diabetes medical devices is common, under-recognized, and expected to increase as device use increases. Skin rash from diabetes medical devices is common, under-recognized, and researchers expect skin rash from diabetes medical devices to increase, according to a study published in the Journal of Diabetes Science and Technology. “Skin rash is seen in association with a broad range of devices.
Corrigendum: Alveolar Macrophages in Lung Cancer: Opportunities and Challenges
To view the content in your browser, please download Adobe Reader or, alternately, you may Download the file to your hard drive. NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.
"Contribution of Adaptive Immunity to Human COPD and Experimental Model" by Farrah Kheradmand, Yun Zhang et al.
Keywords Animals, Humans, Pulmonary Disease, Chronic Obstructive, Pulmonary Emphysema, Emphysema, Lung, Adaptive Immunity, Models, Theoretical, adaptive immunity, autoimmunity, emphysema, exacerbation, T lymphocytes Abstract The pathophysiology of chronic obstructive pulmonary disease (COPD) and the undisputed role of innate immune cells in this condition have dominated the field in the basic research arena for many years.
Alveolar Macrophages in Lung Cancer: Opportunities Challenges
Publication Date 1-1-2023 Journal Frontiers in Immunology DOI 10.3389/fimmu.2023.1268939 PubMedCentral® Posted Date 9-26-2023 PubMedCentral® Full Text Version Post-print Keywords Humans, Macrophages, Alveolar, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung, Inflammation, Tumor Microenvironment, tissue-resident alveolar macrophages, smoking, lung cancer, immune checkpoint inhibitors, tumor-associated macrophages, tumor microenvironment Abstract Alveolar macrophages (AMs) are critical...
The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement
2. Immune enhancement and coronavirus vaccines Beyond direct virus-induced pathology, immune enhancement associated with eosinophilic infiltration and immunopathology is a potential safety concern linked to first-generation vaccines to prevent severe acute respiratory syndrome (SARS) [12]. A similar phenomenon may have derailed early efforts to develop an inactivated whole virus human vaccine against respiratory syncytial virus (RSV) [13].
Has the Biden admin impacted the energy insurance business?
The insurance industry has been keeping a close eye on the administration’s energy initiatives, and thus far what we’ve seen is that while the energy sector is changing, it’s not creating a policy vacuum for insurers. (Credit: Carolyn Kaster/AP, File) It’s been more than a year since Joe Biden became president of the United States, but despite expectations that his administration would rapidly make changes affecting the energy industry, that has not been the case.
New Federal Standards Will Most Certainly Change the Environmental Insurance Landscape. Are You Prepared?
Connected devices are upping the risk mitigation game. For insureds who partner with the right experts, that means a more proactive and faster response in the event of a potential claim. As the world continues to invest in growing technology and the internet of things (IoT) evolves to offer more in the way of risk solutions, it’s no wonder that businesses and their risk teams are looking to utilize the capabilities offered.
Three words underwriters never want to hear
Brokers should steer clear of these snafus when working with insurance underwriters. (Photo: Bacho/Shutterstock) There are three words we, underwriters, never want to hear: “All info forthcoming.”
COVID-19 vaccines: neutralizing antibodies and the alum advantage
Achieving high levels of neutralizing antibodies to the spike protein of SARS-CoV-2 in a safe manner is likely to be crucial for an effective vaccine. Here, we propose that aluminium-based adjuvants might hold the key to this. Scientists are racing to develop safe and effective vaccines to prevent COVID-19, with at least a dozen candidate vaccines already in the clinic or soon to enter clinical development.
The Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement
Working Paper Brief Report Version 1 This version is not peer-reviewed Peter Hotez * , Maria Elena Bottazzi , David Corry Version 1 : Received: 7 April 2020 / Approved: 9 April 2020 / Online: 9 April 2020 (14:45:33 CEST) Hotez, P.; Bottazzi, M.E.; Corry, D. The Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement. Preprints 2020, 2020040159 Hotez, P.; Bottazzi, M.E.; Corry, D.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with David
Contact David, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack